CoChat

Photodynamic therapy with violet light and topical δ‐aminolaevulinic acid in the treatment of actinic keratosis, Bowen’s disease and basal cell carcinoma

Dijkstra, AT, Majoie, IML, Van Dongen, JWF, Van Weelden, H, Van Vloten, WA · 2001 · Journal of the European Academy of Dermatology and Venereology
Cited by 93

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Background Most clinical studies using photodynamic therapy (PDT) with topical application of δ‐aminolaevulinic acid (δ‐ALA) use red light because it allows greater depth of penetration. However, given the porphyrin‐like spectrum of δ‐ALA‐induced photosensitivity, violet light provides a maximal overlap with the excitation spectrum of protoporphyrin IX, meaning that PDT with violet light uses less light energy to induce the phototoxic reaction. Aim To study the efficacy of violet light in combination with topical δ‐ALA PDT in the treatment of premalignant and malignant skin lesions. Methods Eight hours after 20%δ‐ALA was applied topically, photoirradiation was performed with an incoherent light source (Philips HPM‐10, 400 W) emitting predominantly violet light (400–450 nm). Lesions received 10–20 J/cm 2 during an exposure time of 30 min. The 38 subjects treated included three with basal cell naevus syndrome with multiple (> 30) superficial and nodular basal cell carcinomas (BCCs), one subject had multiple lesions of Bowen’s disease, involving 50% of the scalp, and the remaining 34 subjects presented a total of 35 superficial BCCs, 10 nodular BCCs, four large solar keratoses and five solitary lesions of Bowen’s disease. Results Complete remission both clinically and histologically was seen after a single treatment in 82% of the superficial BCCs (100% after a second treatment), 50% of the nodular BCCs, one of the four solar keratosis lesions (partial remission in the other three) and 90–100% of the solitary lesions of Bowen’s disease. Conclusions δ‐ALA PDT using violet light appears to be a well tolerated and effective alternative treatment for premalignant and malignant skin lesions, especially when there are multiple lesions or large patches comprising a large area of skin.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1468-3083.2001.00333.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 93

Metadata

Authors
Dijkstra, A., Majoie, I., Van Dongen, J., Van Weelden, H., & Van Vloten, W.
Venue
Journal of the European Academy of Dermatology and Venereology
Publisher
Wiley
Published
2001-11
Volume
15
Issue
6
Pages
550-554
ISSN
  • 0926-9959 (ISSN-L)
  • 1468-3083
OpenAlex
W2013588209
Cited by
93
References
2
FWCI
3.57
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Photodynamic therapy with violet light and topical δ‐aminolaevulinic acid in the treatment of actinic keratosis, Bowen’s disease and basal cell carcinoma. https://app.cochat.ai/papers/10.1046/j.1468-3083.2001.00333.x
The paper
Dijkstra, A., Majoie, I., Van Dongen, J., Van Weelden, H., & Van Vloten, W. (2001). Photodynamic therapy with violet light and topical δ‐aminolaevulinic acid in the treatment of actinic keratosis, Bowen’s disease and basal cell carcinoma. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1046/j.1468-3083.2001.00333.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.